COVID-19 represents a global health crisis. Several studies are evaluating potential therapies including hydroxychloroquine (HCQ) which is given to patients based on limited observational evidence. However, it can cause serious adverse events. Moreover, recent studies showed no benefits due to HCQ. We present two COVID-19 patients treated with HCQ and had adverse events.
CITATION STYLE
Abdelmaseih, R., Abdelmasih, R., Hasan, M., Tadepalli, S., & Patel, J. (2020). Serious Adverse Events Associated With Hydroxychloroquine Amidst COVID-19 Pandemic: Case Series and Literature Review. Cureus. https://doi.org/10.7759/cureus.8415
Mendeley helps you to discover research relevant for your work.